Art

J-GLOBAL ID：201002240560788987   Reference number：10A0087933

Botulinum Toxin Type A for Migraine Prophylaxis in the Japanese Population: An Open-Label Prospective Trial

日本人集団における片頭痛予防に対するA型ボツリヌス毒素:非盲検前向き試験

Author (3)： SUZUKI Kosuke (Dep. of Neurology, School of Medicine, Kitasato Univ.) ,  IIZUKA Takahiro (Dep. of Neurology, School of Medicine, Kitasato Univ.) ,  SAKAI Fumihiko (Dep. of Neurology, School of Medicine, Kitasato Univ.)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 46  Issue： 13  Page： 959-963 (J-STAGE)  Publication year： 2007 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(sociology) ,...
Semi thesaurus term： Japanese ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=10A0087933&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Reference (16)：

• 1. World Health Organization. World Health Report 2002. Reducing Risks, Promoting Healthy Life. WHO, Geneva, 2002: 194-195.
• 2. Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia 17: 15-22, 1997.
• 3. Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg 123 (6): 669-676, 2000.
• 4. Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin. type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 40 (6): 445-450, 2000.
• 5. Brin MF, Swope DM, O'Brain C, Aboasi S, Pogoda JM. Botox for migraine: Double-blind, Placebo-controlled, region-specific evaluation. Cephalalgia 20: 421-422, 2000.

Terms in the title (6)： 日本人 ,  集団 ,  片頭痛予防 ,  A型ボツリヌス毒素 ,  盲 ,  試験